Clinical Trials Directory

Trials / Completed

CompletedNCT00726440

Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients?

Are the Continous Glucose Monitoring Systems Able to Improve Long Term Glycaemic Control in Type 1 Diabetic Patients With Poor Metabolic Control?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète · Academic / Other
Sex
All
Age
8 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The "Capteur Evadiac" study group, composed of French and Belgian diabetologists, has designed a 1 year randomized controlled multicenter study in order to define what should be the best clinical way of using continuous glucose monitoring in the long term to improve metabolic control in uncontrolled type 1 diabetes patients.

Detailed description

The primary objective of the study is to determine whether patients with chronically poor glycaemic control as evidenced by HbA1c \>= 8% twice can achieve improved metabolic control using during one year CGM together with educative program about insulin adaptation doses compared to conventional self monitoring finger sticks with educative program about insulin adaptation doses alone.

Conditions

Interventions

TypeNameDescription
DEVICENavigator®Patients will be encouraged to use the Navigator® all the time and to modify their treatment according to the device measurments. Patients will also follow and educational process in order to adapt insulin doses according to each sensor data
DEVICENavigator®Patients will follow the same educational process as group1 concerning insulin doses adaptation.The duration of the use of the devicewill be determined at the consultation every each 3 months.
DEVICEPlaceboPatients will have their usual follow up with self-monitoring blood glucose

Timeline

Start date
2008-02-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2008-08-01
Last updated
2012-02-09

Locations

19 sites across 2 countries: Belgium, France

Source: ClinicalTrials.gov record NCT00726440. Inclusion in this directory is not an endorsement.